Laura Cacciaguerra

Neurology

200 1st St Sw
Rochester, MN 55905

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results.

TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 13, 2026

Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Journal: JAMA neurology

Published: July 13, 2026

Analysis of MOG-IgG and AQP4-IgG Serology, Demographics, and Seasonality From Large Neuroimmunology Laboratory Registry and Clinical Cohorts.

Analysis of MOG-IgG and AQP4-IgG Serology, Demographics, and Seasonality From Large Neuroimmunology Laboratory Registry and Clinical Cohorts.

Journal: Neurology open access

Published: April 20, 2026

TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results.

TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: April 01, 2026

Investigating the Frequency and Outcome of Central Vein Sign and Paramagnetic Rim Lesions in Children With MOGAD.

Investigating the Frequency and Outcome of Central Vein Sign and Paramagnetic Rim Lesions in Children With MOGAD.

Journal: Neurology

Published: January 09, 2026

Psychiatric comorbidities cluster early after onset in MOGAD: a cross-sectional comparative study with MS and NMOSD.

Psychiatric comorbidities cluster early after onset in MOGAD: a cross-sectional comparative study with MS and NMOSD.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: December 25, 2025

Expanding Evidence of Leptomeningeal Involvement in MOGAD and Its Relevance to Its Pathophysiology.

Expanding Evidence of Leptomeningeal Involvement in MOGAD and Its Relevance to Its Pathophysiology.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: November 18, 2025

Outcomes After Acute Plasma Exchange for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Outcomes After Acute Plasma Exchange for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Journal: Neurology

Published: August 29, 2025

Application of the ADEM definition to cerebral attacks of MOG antibody-associated disease.

Application of the ADEM definition to cerebral attacks of MOG antibody-associated disease.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: August 19, 2025

Meningitis as an Attack Phenotype of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Meningitis as an Attack Phenotype of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Journal: JAMA neurology

Published: June 16, 2025

Assessment of increased opening pressure in patients with multiple sclerosis and aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder.

Assessment of increased opening pressure in patients with multiple sclerosis and aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: May 26, 2025

MRI characteristics during attack and remission distinguish patients with MOG antibody-associated disease from multiple sclerosis.

MRI characteristics during attack and remission distinguish patients with MOG antibody-associated disease from multiple sclerosis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: May 06, 2025

Showing 1-12 of 64

Last Updated: 09/26/2026